These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 18248437)
1. Commonly invasive serotypes of Streptococcus pneumoniae trigger a reduced innate immune response compared with serotypes rarely responsible for invasive infection. Burgess TS; Hirschfeld AF; Tyrrell GJ; Bettinger JA; Turvey SE FEMS Immunol Med Microbiol; 2008 Jun; 53(1):136-9. PubMed ID: 18248437 [TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Pletz MW; Maus U; Krug N; Welte T; Lode H Int J Antimicrob Agents; 2008 Sep; 32(3):199-206. PubMed ID: 18378430 [TBL] [Abstract][Full Text] [Related]
3. Changes in Streptococcus pneumoniae serotypes causing invasive disease with non-universal vaccination coverage of the seven-valent conjugate vaccine. Aguiar SI; Serrano I; Pinto FR; Melo-Cristino J; Ramirez M; Clin Microbiol Infect; 2008 Sep; 14(9):835-43. PubMed ID: 18844684 [TBL] [Abstract][Full Text] [Related]
4. Virulence in mice of pneumococcal clonal types with known invasive disease potential in humans. Sandgren A; Albiger B; Orihuela CJ; Tuomanen E; Normark S; Henriques-Normark B J Infect Dis; 2005 Sep; 192(5):791-800. PubMed ID: 16088828 [TBL] [Abstract][Full Text] [Related]
5. Emergence of Streptococcus pneumoniae serotypes 19A, 6C, and 22F and serogroup 15 in Cleveland, Ohio, in relation to introduction of the protein-conjugated pneumococcal vaccine. Jacobs MR; Good CE; Bajaksouzian S; Windau AR Clin Infect Dis; 2008 Dec; 47(11):1388-95. PubMed ID: 18959493 [TBL] [Abstract][Full Text] [Related]
6. Incidence of invasive pneumococcal disease in the Czech Republic and serotype coverage by vaccines, 1997-2006. Motlova J; Benes C; Kriz P Epidemiol Infect; 2009 Apr; 137(4):562-9. PubMed ID: 18796171 [TBL] [Abstract][Full Text] [Related]
7. The transforming Streptococcus pneumoniae in the 21st century. Hsieh YC; Lee WS; Shao PL; Chang LY; Huang LM Chang Gung Med J; 2008; 31(2):117-24. PubMed ID: 18567411 [TBL] [Abstract][Full Text] [Related]
8. Comparison of the pulmonary response against lethal and non-lethal intranasal challenges with two different pneumococcal strains. Ferreira DM; Moreno AT; Cianciarullo AM; Ho PL; Oliveira ML; Miyaji EN Microb Pathog; 2009 Sep; 47(3):157-63. PubMed ID: 19467320 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneity of pneumococcal phase variants in invasive human infections. Serrano I; Melo-Cristino J; Ramirez M BMC Microbiol; 2006 Jul; 6():67. PubMed ID: 16872486 [TBL] [Abstract][Full Text] [Related]
10. Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Rodgers GL; Arguedas A; Cohen R; Dagan R Vaccine; 2009 Jun; 27(29):3802-10. PubMed ID: 19446378 [TBL] [Abstract][Full Text] [Related]
11. Recognition of Streptococcus pneumoniae by the innate immune system. Koppe U; Suttorp N; Opitz B Cell Microbiol; 2012 Apr; 14(4):460-6. PubMed ID: 22212419 [TBL] [Abstract][Full Text] [Related]
12. Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study. Kellner JD; Vanderkooi OG; MacDonald J; Church DL; Tyrrell GJ; Scheifele DW Clin Infect Dis; 2009 Jul; 49(2):205-12. PubMed ID: 19508165 [TBL] [Abstract][Full Text] [Related]
13. [Epidemiological features of invasive pneumococcal disease before and after the introduction of pneumococcal conjugate vaccine in Gran Canaria (Canary Islands)]. Artiles F; Horcajada I; Cañas AM; Alamo I; Bordes A; González A; Santana M; Lafarga B Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):14-21. PubMed ID: 19217998 [TBL] [Abstract][Full Text] [Related]
14. Surveillance for invasive Streptococcus pneumoniae disease among hospitalized children in Bangladesh: antimicrobial susceptibility and serotype distribution. Saha SK; Naheed A; El Arifeen S; Islam M; Al-Emran H; Amin R; Fatima K; Brooks WA; Breiman RF; Sack DA; Luby SP; Clin Infect Dis; 2009 Mar; 48 Suppl 2():S75-81. PubMed ID: 19191622 [TBL] [Abstract][Full Text] [Related]
16. What is different about serotype 1 pneumococci? Ritchie ND; Mitchell TJ; Evans TJ Future Microbiol; 2012 Jan; 7(1):33-46. PubMed ID: 22191445 [TBL] [Abstract][Full Text] [Related]
17. Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae. Dagan R Clin Microbiol Infect; 2009 Apr; 15 Suppl 3():16-20. PubMed ID: 19366365 [TBL] [Abstract][Full Text] [Related]
18. Re: Global serotype distribution among Streptococcus pneumoniae isolates causing otitis media in children: potential implications for pneumococcal conjugate vaccines. Prymula R Vaccine; 2009 Jul; 27(35):4739-40. PubMed ID: 19540951 [TBL] [Abstract][Full Text] [Related]
19. Age- and serotype-specific pediatric invasive pneumococcal disease: insights from systematic surveillance in Santiago, Chile, 1994--2007. Lagos R; Muñoz A; San Martin O; Maldonado A; Hormazabal JC; Blackwelder WC; Levine MM J Infect Dis; 2008 Dec; 198(12):1809-17. PubMed ID: 18959497 [TBL] [Abstract][Full Text] [Related]
20. Serotype distribution and antimicrobial resistance patterns of Streptococcus pneumoniae isolated from children in China younger than 5 years. Liu Y; Wang H; Chen M; Sun Z; Zhao R; Zhang L; Wang H; Zhang H; Wang L; Chu Y; Liu Y; Ni Y Diagn Microbiol Infect Dis; 2008 Jul; 61(3):256-63. PubMed ID: 18358662 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]